---

Farhad Hafezi

As a post-doc, Farhad Hafezi identified a gene that can completely inhibit light-induced retinal damage in mice. Today his clinical focus is on corneal and refractive laser surgery, and he is a pioneer of corneal collagen cross-linking (CXL). Hafezi was instrumental in building IROC in Zurich, where CXL technology underwent further clinical development.

---

Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014